National Cancer Institute
Found 876 results for your search:
Total relevant funding to Prostate for this search:
$233,034,406
Fiscal Year FY 2017
Cancer Type [Prostate]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 876 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(1 of 2) Florida Minority Cancer Research & Training Center: Feasibility Studies 5P20CA192990-04 $165,747 $99,448 REAMS, ROMONIA FLORIDA AGRICULTURAL AND MECHANICAL UNIV
2
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities 5U54CA143930-08 $704,474 $112,716 FARIAS-EISNER, ROBIN UNIVERSITY OF CALIFORNIA LOS ANGELES
3
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment 5R01CA185457-04 $640,378 $640,378 FRANGIONI, JOHN CURADEL, LLC
4
(PQC4) Habitats in Prostate Cancer 5R01CA190105-04 $681,586 $681,586 GILLIES, ROBERT H. LEE MOFFITT CANCER CTR & RES INST
5
(PQD-1) Selective pressure of antiandrogens on castration resistant prostate canc 5R01CA185509-04 $258,128 $258,128 GHOSH, PARAMITA UNIVERSITY OF CALIFORNIA AT DAVIS
6
0021.0001 CG 425 METAVIVOR 261200800001E $319,219,481 $263,827 UNKNOWN, UNKNOWN LEIDOS BIOMEDICAL RESEARCH, INC.
7
1/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 5P20CA202924-02 $229,982 $80,494 WILLIAMS, KEVIN NORTH CAROLINA CENTRAL UNIVERSITY
8
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192973-04 $191,836 $95,918 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
9
1/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities 1P20CA221697-01 $324,559 $3,246 REITZEL, LORRAINE UNIVERSITY OF HOUSTON
10
2/2 Florida Minority Cancer Research & Training Center: Feasibility Studies 5P20CA192992-04 $158,966 $111,276 ODEDINA, FOLAKEMI UNIVERSITY OF FLORIDA
11
2/2 NCCU-DUKE Cancer Disparities Translational Research Partnership 5P20CA202925-02 $255,626 $194,276 PATIERNO, STEVEN DUKE UNIVERSITY
12
2/2 NCCU-LCCC Partnership in Cancer Research 5U54CA156733-08 $919,471 $18,389 EARP, HENRY UNIV OF NORTH CAROLINA CHAPEL HILL
13
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership 5P20CA192976-04 $144,556 $67,941 MISHRA, MANOJ ALABAMA STATE UNIVERSITY
14
2/2 U-HAND (University of Houston/MD Anderson) Program to Reduce Cancer Disparities 1P20CA221696-01 $221,442 $44,288 MCNEILL, LORNA UNIVERSITY OF TX MD ANDERSON CAN CTR
15
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 5U54CA118623-12 $407,680 $179,379 TROY, ROBERTA TUSKEGEE UNIVERSITY
16
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership 5U54CA118948-12 $1,170,535 $105,348 MANNE, UPENDER UNIVERSITY OF ALABAMA AT BIRMINGHAM
17
3D Prostate Histochemometry to Predict Disease Recurrence 5R01CA197516-02 $400,626 $400,626 BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
18
402 -- A PHASE I TRIAL OF THE SAFETY IMMUNOGENICITY OF RG1-VLP... (PROTOCOL UWI2016-08-02). CONTRACTOR: UNIVERSITY OF WISCONSIN. CONTRACT NO: HHSN261201200033I, TASK ORDER: HHSN261000012. FROM 9/1 261201200033I $1,485,915 $490,352 UNKNOWN, UNKNOWN UNIVERSITY OF WISCONSIN-MADISON
19
402 -- CHEMOPREVENTION OF COLORECTAL CANCER . CONTRACTOR: UNIVERSITY OF OKLAHOMA, HEALTH SCIENCES CENTER, DUNS: 878648294. CONTRACT NO: HHSN261500038I, TASK ORDER HHSN26100011. FROM 9/15/17 TO 9/14/ 261201500038I $1,236,052 $1,236,052 UNKNOWN, UNKNOWN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
20
A blood test to identify prostate cancer patients at risk for visceral metastasis 1R01CA218356-01 $620,500 $620,500 POSADAS, EDWIN CEDARS-SINAI MEDICAL CENTER
21
A highly specific NIRF/PET probe for the detection of cancer and metastases 1R43CA210854-01A1 $224,958 $112,479 Yang, Xinlin IMOL RADIOPHARMACEUTICALS, LLC
22
A Mitogen-induced G Protein-coupled Receptor ZIA SC 009389 $151,467 $75,733 Kelly Siebenlist, Kathleen CCR (NCI)
23
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials 5R01CA200718-02 $599,514 $599,514 EGGLY, SUSAN WAYNE STATE UNIVERSITY
24
A New Mechanism for Castration Resistant Prostate Cancer 5R01CA166894-05 $1 $1 SUN, ZIJIE BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
25
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use 5R01CA207645-02 $558,907 $558,907 WEBER, WOLFGANG SLOAN-KETTERING INST CAN RESEARCH
26
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS 2R44CA183362-02A1 $822,075 $411,038 SALVINO, JOSEPH ALLIANCE DISCOVERY, INC.
27
A novel strategy to identify prostate cancer biomarkers for patient management 5R01CA172603-05 $329,925 $329,925 HUANG, JIAOTI DUKE UNIVERSITY
28
A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR 5R01CA200551-02 $247,249 $247,249 PARK, SEAN MAYO CLINIC ROCHESTER
29
A Small-Molecule Inhibitor of the Terminal Steps for Intracrine Androgen Synthesis in Advanced Prostate Cancer 5R21CA205108-02 $259,734 $259,734 MOHLER, JAMES ROSWELL PARK CANCER INSTITUTE CORP
30
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors 5R21CA198237-02 $88,993 $17,799 DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES
31
A Target-Directed Reagent Pipeline via Microfluidic mRNA Display 1R21CA204708-01A1 $227,675 $113,838 MALMSTADT, NOAH UNIVERSITY OF SOUTHERN CALIFORNIA
32
AARP prospective study of diet and cancer ZIA CP010196-03152 $703,174 $35,159 Sinha, Rashmi DCEG (NCI)
33
Abramson Cancer Center Support Grant 3P30CA016520-41S1 $125,000 $2,500 DANG, CHI UNIVERSITY OF PENNSYLVANIA
34
Abramson Cancer Center Support Grant 3P30CA016520-41S2 $62,491 $1,250 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
35
Abramson Cancer Center Support Grant 5P30CA016520-41 $7,810,244 $156,205 VONDERHEIDE, ROBERT UNIVERSITY OF PENNSYLVANIA
36
Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention 1R01CA204254-01A1 $376,753 $376,753 FEI, BAOWEI EMORY UNIVERSITY
37
Activatable molecular cancer imaging probe ZIA BC 011512 $256,560 $51,312 Kobayashi, Hisataka CCR (NCI)
38
Active surveillance and patient reported outcomes in a diverse population of prostate cancer patients 1R01CA211141-01A1 $664,142 $664,142 GOMEZ, SCARLETT UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
39
Adaptive resistance to HIF1a inhibition in hypoxia 5R01CA207377-02 $352,147 $116,209 QIAN, ZHENG DAVID OREGON HEALTH & SCIENCE UNIVERSITY
40
Advanced statistical modeling and analytics for prostate cancer interventions 1R50CA221836-01 $202,176 $202,176 GULATI, ROMAN FRED HUTCHINSON CANCER RESEARCH CENTER
41
Advancement and Validation of Prostate Diffusion and Spectroscopic MRI 5R01CA160902-06 $220,860 $220,860 MAIER, STEPHAN BRIGHAM AND WOMEN'S HOSPITAL
42
Aggressive Prostate Cancer: Linking Epigenomics and Genetics for Prevention 5K05CA175147-04 $88,959 $88,959 STANFORD, JANET FRED HUTCHINSON CANCER RESEARCH CENTER
43
Agricultural Cohort Consortium ZIA CP010119-10537 $50,451 $5,045 Beane Freeman, Laura DCEG (NCI)
44
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-04S1 $2,088,480 $125,309 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
45
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-04 $11,145,123 $668,707 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
46
Alteration of the miR-let-7c:Lin28 ratio as a predictor of therapy resistance in Prostate Cancer 1R03CA198696-01A1 $76,750 $76,750 NADIMINTY, NAGALAKSHMI UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
47
An inevitable mechanism of resistance to androgen-directed therapy 5R01CA188609-04 $312,288 $312,288 DONG, YAN TULANE UNIVERSITY OF LOUISIANA
48
An integrated approach to dissect the functional network of large non-coding RNA 5R00CA175290-05 $221,939 $221,939 CHEN, YIWEN UNIVERSITY OF TX MD ANDERSON CAN CTR
49
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer 5R01CA208254-02 $481,793 $481,793 SWEENEY, CHRISTOPHER DANA-FARBER CANCER INST
50
Analysis of drug response in organoids and mouse models 5R01CA196662-02 $597,601 $597,601 SHEN, MICHAEL COLUMBIA UNIVERSITY HEALTH SCIENCES
Total relevant funding to Prostate for this search: $233,034,406
Showing 1 - 50 of 876 results
Go to top